In this special session, Dr. Bersell provides a comprehensive overview of RNA interference (RNAi) technology and its groundbreaking applications in treating ATTR-CM and ATTR-PN (Polyneuropathy). This expert-led discussion explores the mechanism of action, clinical evidence, patient outcomes, and the future of RNAi therapeutics for ATTR Patients (both hereditary and wild type).
